Scarica l'app Stockscreener
13.64
1.87%
0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.39
Aprire:
$13.5
Volume 24 ore:
1.66M
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.34B
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-5.5673
EPS:
-2.45
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
+4.44%
1M Prestazione:
+13.10%
6M Prestazione:
+92.66%
1 anno Prestazione:
+80.90%
Intervallo 1D:
$13.24
$13.67
Intervallo di 1 settimana:
$12.85
$13.67
Portata 52W:
$4.70
$14.43
Mind Medicine Inc Stock (MNMD) Company Profile
Nome
Mind Medicine Inc
Settore
Industria
Telefono
212-220-6633
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Confronta MNMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
13.64 | 1.32B | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-08-04 | Ripresa | Oppenheimer | Outperform |
| 2025-01-28 | Iniziato | Evercore ISI | Outperform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-10-14 | Ripresa | Leerink Partners | Outperform |
| 2024-07-24 | Iniziato | ROTH MKM | Buy |
| 2024-05-29 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | Canaccord Genuity | Buy |
| 2022-12-09 | Ripresa | ROTH Capital | Buy |
| 2022-11-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-26 | Iniziato | Oppenheimer | Outperform |
| 2022-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Iniziato | ROTH Capital | Buy |
| 2021-06-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Mind Medicine Inc Borsa (MNMD) Ultime notizie
Is Mind Medicine MindMed Inc a good long term investmentTrendline Breakouts & Low Cost Portfolio Growth - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT) and Mind Medicine (MNMD) - The Globe and Mail
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.8% on Insider Selling - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Daniel Karlin Sells 5,600 Shares - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $339,151.65 in Stock - MarketBeat
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 3.1%Should You Buy? - MarketBeat
Will Mind Medicine (MindMed) Inc. (MMQ) stock sustain uptrend momentumFundamental Stock Analysis & Minimal Investment Trading Plans - bollywoodhelpline.com
What’s driving JonesTrading’s bullish view on Mind Medicine (MindMed) Inc. (MNMD) - MSN
Aug Momentum: Is Mind Medicine MindMed Inc stock a safe investment in uncertain markets2025 Risk Factors & Verified Short-Term Plans - moha.gov.vn
What’s Driving JonesTrading’s Bullish View on Mind Medicine (MindMed) Inc. (MNMD) - Insider Monkey
MindMed Expands Into Autism: What Investors Should Know About the New MM402 Trial - TipRanks
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from Analysts - MarketBeat
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is MindMed (MNMD) Turning Psychedelic Policy Tailwinds Into a Durable Neuropsychiatry Advantage? - Sahm
Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026 - Yahoo Finance
Trading Systems Reacting to (MNMD) Volatility - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 4.3%Here's What Happened - MarketBeat
Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? - Stocktwits
Jones Trading Initiates Coverage of Mind Medicine (MNMD) with Buy Recommendation - Nasdaq
Jones Trading initiates coverage of Mind Medicine (MNMD) with buy recommendation - MSN
Jones Trading Initiates Coverage on Mind Medicine (MNMD) with 'B - GuruFocus
Jones Trading initiates coverage on MindMed stock with Buy rating By Investing.com - Investing.com South Africa
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpTime to Buy? - MarketBeat
MindMed a new buy at Jones on promise of psychedelics for mental illnesses - Seeking Alpha
Jones Trading Begins Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Jones Trading initiates coverage on MindMed stock with Buy rating - Investing.com
Mind Medicine (MNMD) Receives a Rating Update from a Top Analyst - The Globe and Mail
Mind Medicine Inc Stock Intrinsic Values - GuruFocus
Mind Medicine (FRA:MMQ) EV-to-OCF : -9.03 (As of Dec. 21, 2025) - GuruFocus
New Highs: Will Mind Medicine (MindMed) Inc. (MMQ) stock sustain uptrend momentumJuly 2025 Setups & Verified Entry Point Detection - Улправда
Is Mind Medicine (MindMed) Inc. stock oversold or undervalued - Улправда
How Mind Medicine (MindMed) Inc. stock benefits from tech adoptionWeekly Trend Report & Technical Pattern Based Signals - Улправда
Psychedelics stocks could benefit from marijuana rescheduling: Jefferies - Seeking Alpha
Can Mind Medicine (MindMed) Inc. stock surprise with earnings upsideQuarterly Performance Summary & High Win Rate Trade Tips - DonanımHaber
Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance
Nasdaq Moves: What makes Mind Medicine (MindMed) Inc. stock attractive to growth fundsJuly 2025 Trends & Long-Term Growth Stock Strategies - moha.gov.vn
MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
RSI Check: Is Mind Medicine (MindMed) Inc. stock oversold or undervalued2025 Sector Review & Trade Opportunity Analysis - Улправда
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - Finviz
MindMed Announces New Employee Inducement Grant - Business Wire
Mind Medicine (HAM:MMQ) EV-to-FCF : -8.89 (As of Dec. 13, 2025) - GuruFocus
Avoiding Lag: Real-Time Signals in (MNMD) Movement - news.stocktradersdaily.com
MindMed Secures $259 Million in Public Offering to Advance Brain Health Innovations - MSN
Stempoint Capital LP Makes New $590,000 Investment in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Diadema Partners LP Makes New Investment in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 4.6%Here's Why - MarketBeat
MindMed stock soars 73% after InvestingPro’s undervalued call in May 2024 By Investing.com - Investing.com
Marshall Wace LLP Has $22.20 Million Holdings in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Mind Medicine Inc Azioni (MNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mind Medicine Inc Azioni (MNMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer |
Dec 26 '25 |
Sale |
13.15 |
25,791 |
339,072 |
778,477 |
| Sullivan Mark | Chief Legal Officer |
Dec 26 '25 |
Sale |
13.15 |
11,276 |
148,244 |
282,576 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):